An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim in the first Zantac verdict in the nation.
Thursday's defense win, in the Cook County Circuit Court, comes as thousands of other cases have alleged that the over-the-counter heartburn medication the U.S. Food and Drug Administration recalled in 2020 caused various forms of cancer.
And the verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the multidistrict litigation.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.